Hong Kong Exchanges and Clearing Limited

FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation

Form Serial Number:

DA20220421E00453
(Amendment to DA20220421E00279)

1. Date of relevant event:

14/04/2022
(dd/mm/yyyy)

2. Date when director became aware of the relevant event/ interest in the shares (if later):

(dd/mm/yyyy)

3. Stock code:

06606

4. Name of listed corporation:

New Horizon Health Limited - B

5. Class of shares:

Ordinary Shares

6. Number of issued shares in class:

429,739,898

7. Name of director (English) as printed on HKID Card/Passport:

(Surname)	Zhu
(Other names)	Yeqing

10. Name of director (Chinese):

朱葉青

11. Chinese Character Code as printed on HKID Card:

24. Details of relevant event:

Brief description of relevant event

Capacity in which shares were/are held

Number of shares bought/sold or involved

Currency of transaction

On Exchange

Off Exchange

Before relevant event

After relevant event

Highest price (per share)

Average price (per share)

Average consideration (per share)

Consideration code

Long position

11031

The number of shares in which you are interested has increased because:
you became the holder of, wrote or issued equity derivatives under which (choose one):
you have a right to take the underlying shares

2101	Beneficial owner

960,600

Short position

25. Total shares in listed corporation immediately before the relevant event:

	Total number of shares	Percentage figure (%)
Long position	28,146,010	6.55

26. Total shares in listed corporation immediately after the relevant event:

	Total number of shares	Percentage figure (%)
Long position	29,106,610	6.77

27. Capacity in which interests disclosed in Box 26 are held:

Code describing capacity

Number of shares

2305	Beneficiary of a trust (other than a discretionary interest)

Long position

28,146,010

2101	Beneficial owner

Long position

960,600

28. Further information in derivative interests in listed corporation :

Derivatives code

Exercise period (dd/mm/yyyy)

Consideration - if derivatives granted by listed corporation

Number of shares

Begins

Ends

Currency

Price for grant

Currency

Exercise price

Currency

Price on assignment

Long position

4101	Listed derivatives - Physically settled

14/04/2026

USD

0.000

480,300

Long position

4101	Listed derivatives - Physically settled

14/04/2023

USD

0.000

480,300

29. Further information in relation to interests of children under 18 and/or spouse:

Child/Spouse	Name of child/spouse	Number of shares

30. Further information in relation to interests of corporations controlled by Director:

Name of controlled corporation	Address and place of incorporation	Name of controlling person	% control	Direct interest (Y/N)	Number of shares

31. Further information in relation to interests held by Director jointly with another person:

Name of joint shareholder	Address	Number of shares

32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:

Names of Trust	Address	Status code	Number of shares

33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):

Names of other parties	Address	Number of shares

Total number of shares in which a director is interested under sections 317 and 318

34. Supplementary information:

Zhu Yeqing was granted in aggregate 960,600 restricted share units, representing 960,600 ordinary shares of New Horizon Health Limited subject to certain vesting conditions under the pre-IPO share incentive plan adopted and approved on October 10, 2018 and further amended and approved on August 17, 2020.

35. Log/Serial Number of the previous form:

DA20220421E00279

36. Number of concert party document(s) under section 317 attached/uploaded:

Date of filing this Form 3A:

21/04/2022
(dd/mm/yyyy)